Phenotypes associated with this allele
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ptpn11tm1Bgn mutation
(1 available);
any
Ptpn11 mutation
(43 available)
|
|
|
mortality/aging
|
• homozygous embryos die around E13.5
|
cardiovascular system
|
• the myocardium is markedly thinner compared to wild-type
|
|
• enlarged outflow tract and atrioventricular valve primordia are seen
|
|
• at E13.5 atrial septal defects are seen
|
|
• at E13.5 atrioventricular septal defects are seen
|
|
• at E13.5 ventricular and atrioventricular septal defects are seen
|
|
• pericardial effusions are seen
|
|
• at E13.5 embryos are grossly hemorrhagic
|
|
• decreased apoptosis is seen in endocardial cushions
|
cellular
|
• decreased apoptosis is seen in endocardial cushions
|
|
• at E13.5 severe liver necrosis is seen
|
|
• increased cellular proliferation is seen in endocardial cushions
|
homeostasis/metabolism
liver/biliary system
|
• at E13.5 severe liver necrosis is seen
|
|
• at E13.5 decreased liver size is seen
|
muscle
|
• the myocardium is markedly thinner compared to wild-type
|
|
• decreased apoptosis is seen in endocardial cushions
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ptpn11tm1Bgn mutation
(1 available);
any
Ptpn11 mutation
(43 available)
|
|
|
mortality/aging
N |
• Background Sensitivity: unlike mice on a congenic C57BL/6 background nearly all mice survive
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ptpn11tm1Bgn mutation
(1 available);
any
Ptpn11 mutation
(43 available)
|
|
|
mortality/aging
|
• Background Sensitivity: penetrance of lethality is increased compared to mice on a 129S6/SvEv or BALB/c congenic background and to mice on a mixed 129S4/SvJae and C57BL/6 background
• almost all mice die
|
cardiovascular system
|
• all mice show severe cardiac defects
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ptpn11tm1Bgn mutation
(1 available);
any
Ptpn11 mutation
(43 available)
|
|
|
mortality/aging
|
• about 50% of mice die either in late gestation or perinatally
• Background Sensitivity: penetrance of lethality is decreased compared to mice on a congenic C57BL/6 background
|
Allelic Composition |
Ptpn11tm1Bgn/Ptpn11+
|
|
Genetic Background |
involves: 129S4/SvJae * C57BL/6 |
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ptpn11tm1Bgn mutation
(1 available);
any
Ptpn11 mutation
(43 available)
|
|
|
mortality/aging
|
• about 50% of mice die either in late gestation or perinatally
• Background Sensitivity: penetrance of lethality is decreased compared to mice on a congenic C57BL/6 background
|
cardiovascular system
|
• from 24 - 48 hours in culture endocardial cushions from E9.5 embryos give rise to more mesenchymal cells compared to wild-type controls
• expression analysis indicates that enhanced production of mesenchymal cells is due to a prolongation of the normal interval during which EMT occurs
|
growth/size/body
hematopoietic system
|
• increase in the number of CFU-GM in the absence of cytokines compared to wild-type controls
|
vision/eye
|
• increased inner canthal distance
|
Allelic Composition |
Ptpn11tm1Bgn/Ptpn11+
|
|
Genetic Background |
involves: 129S4/SvJae * C57BL/6J |
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ptpn11tm1Bgn mutation
(1 available);
any
Ptpn11 mutation
(43 available)
|
|
|
mortality/aging
|
• at E18.5 some heterozygous embryos are dead and about 50% fewer than expected heterozygotes are found at weaning
|
cardiovascular system
|
• enlarged atrioventricular valve primordia are seen in about 50% of heterozygotes (severely affected mutants)
|
|
• double outlet right ventricle is seen in about 50% of heterozygotes (severely affected mutants)
|
|
• enlarged mitral valves are seen in about 50% of heterozygotes (not severely affected) at E13.5 but not at E18.5
|
|
• at E13.5 ventricular septal defects are seen in about 50% of heterozygotes (severely affected mutants)
|
|
• decreased apoptosis is seen in endocardial cushions from some heterozygous mutants
|
cellular
|
• decreased apoptosis is seen in endocardial cushions from some heterozygous mutants
|
|
• at E13.5 some heterozygotes display mild liver damage
|
|
• increased cellular proliferation is seen in endocardial cushions from some heterozygous mutants
|
craniofacial
|
• consistent with the decreased body size the skull is smaller than normal however width is not different from wild-type resulting in a greater length/width ratio
|
|
• a wider and blunter snout shape is seen
|
|
• a wider and blunter snout shape is seen
|
growth/size/body
|
• a wider and blunter snout shape is seen
|
|
• a wider and blunter snout shape is seen
|
|
• a significant reduction in body weight and length is seen without altering overall body proportions
|
|
• a significant reduction in body weight and length is seen without altering overall body proportions
|
|
• older heterozygotes develop splenomegaly with mild myeloid and erythroid hyperplasia
|
hematopoietic system
|
• older heterozygotes develop splenomegaly with mild myeloid and erythroid hyperplasia
|
|
• mild myeloid hyperplasia is seen in the bone marrow of older heterozygotes
|
|
• by 5 months heterozygotes develop mild leukocytosis with normal hematocrit and platelet counts
|
immune system
|
• older heterozygotes develop splenomegaly with mild myeloid and erythroid hyperplasia
|
|
• mild myeloid hyperplasia is seen in the bone marrow of older heterozygotes
|
|
• by 5 months heterozygotes develop mild leukocytosis with normal hematocrit and platelet counts
|
liver/biliary system
|
• at E13.5 some heterozygotes display mild liver damage
|
skeleton
|
• consistent with the decreased body size the skull is smaller than normal however width is not different from wild-type resulting in a greater length/width ratio
|
muscle
|
• decreased apoptosis is seen in endocardial cushions from some heterozygous mutants
|